| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 06/19/2008 | CA2671845A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 06/18/2008 | EP1932844A1 Bridged cyclic amine compound and pest control agent |
| 06/18/2008 | EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 06/18/2008 | EP1931681A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 06/18/2008 | EP1931680A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 06/18/2008 | EP1931679A1 Analogs of salinosporamide a |
| 06/18/2008 | EP1931664A2 Methods of modulating neurotrophin-mediated activity |
| 06/18/2008 | EP1931652A2 Amido compounds and their use as pharmaceuticals |
| 06/18/2008 | EP1931636A1 Isoquinolines as igf-1r inhibitors |
| 06/18/2008 | EP1931630A1 N-substituted 3,4-alkylenedioxypyrroles, ester substituted dihydroxypyrroles and methods for synthesis of these pyrroles |
| 06/18/2008 | EP1587807B1 1,2-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 06/18/2008 | EP1232160B1 Spiro(2h-1-benzopyran-2,4'-piperidine)derivates as glycine transport inhibitors |
| 06/18/2008 | EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/18/2008 | CN101203491A Tetrahydrocarbazole derivatives used as androgen receptor modifier |
| 06/18/2008 | CN101200470A Cyclo c-glycosides compounds, c-glycosides intermediates as well as preparation method and uses thereof |
| 06/17/2008 | USRE40387 7,11-dihydroxy 8,8,10,12,16-pentamethyl-3-(1-methyl-2-(2-methyl-4-thiazolyl) ethenyl-17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione and neutralizing buffer in an amount sufficient to reduce its decomposition; increasing the bioavailability of orally administered epothilones; anticarcinogenic agent |
| 06/17/2008 | US7388096 Crystalline forms of a factor Xa inhibitor |
| 06/17/2008 | CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/17/2008 | CA2331737C Agents for relieving side effects caused by use of an anti-tumour agent |
| 06/17/2008 | CA2330798C Febrifugine, isofebrifugine and method for producing the same |
| 06/17/2008 | CA2202487C Fused pyrrolocarbazoles |
| 06/12/2008 | WO2008070740A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 06/12/2008 | WO2008070661A1 Substituted pyrimidines as adenosine receptor antagonists |
| 06/12/2008 | WO2008069997A1 Substituted diazepan compounds as orexin receptor antagonists |
| 06/12/2008 | WO2008069311A1 Tricyclic compound and medical use thereof |
| 06/12/2008 | WO2008068185A1 Spiro-piperidine derivatives as via receptor antagonists |
| 06/12/2008 | WO2008068184A1 Indoles which act as via receptor antagonists |
| 06/12/2008 | WO2008067911A1 Biphenyl-substituted spirocyclic ketoenols |
| 06/12/2008 | US20080139807 Catalytic dehydrogenation with gaseous hydrogen of 11a,10b-dihydro-6H-dibenz/b,f/oxireno[d] azepine-6-carboxamide; anticonvulsant; chemical intermediate |
| 06/12/2008 | US20080139619 Novel derivatives of benzimidazale and imidazo-pyridine and their use as medicaments |
| 06/12/2008 | US20080139603 Azabicycloalkane compounds |
| 06/12/2008 | US20080139602 e.g. 5-{3-[4-(4-Chloro-phenyl)-4-hydroxy-3,3-dimethyl-piperidin-1-yl]-propylidene}-1-oxy-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cycloheptene-7-carboxylic acid; chemokine receptor antagonist; antiinflammatory, antidiabetic agent; antiallergen; arteriosclerosis, asthma, arthritis |
| 06/12/2008 | US20080139600 e.g. N,N-dimethyl-1-{5-[(2R)-3'H-spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridin]-5'-yl]-2-thienyl}methenamine; anxiolytic agent, antidepressant, cognition activator; neurodegenerative disorders: Alzheimer's, Parkinson's, Huntington's diseases, Tourette's syndrome, schizophrenia |
| 06/12/2008 | US20080139509 Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs |
| 06/12/2008 | DE102006057612A1 New spiro compounds useful as photo-adjustable catalysts in organic synthesis and as photo-catalysts in the polymerization reaction |
| 06/12/2008 | CA2671782A1 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 06/12/2008 | CA2671354A1 Tricyclic compound and medical use thereof |
| 06/12/2008 | CA2671324A1 Indoles which act as via receptor antagonists |
| 06/12/2008 | CA2671179A1 Biphenyl-substituted spirocyclic ketoenols |
| 06/12/2008 | CA2670892A1 Substituted diazepan compounds as orexin receptor antagonists |
| 06/12/2008 | CA2670674A1 Spiro-piperidine derivatives as via receptor antagonists |
| 06/11/2008 | EP1928883A2 Process for the preparation of irinotecan hydrochloride |
| 06/11/2008 | EP1928856A1 Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| 06/11/2008 | EP1480984B1 Condensed camptothecins as antitumor agents |
| 06/11/2008 | CN101198613A Substituted tetrahydroquinoline |
| 06/11/2008 | CN101198595A Aspartyl protease inhibitors |
| 06/11/2008 | CN101198594A Process for the production of intermadiates for the preparation of tricyclic benzimidazoles |
| 06/11/2008 | CN101195628A Rifabutin crystallization technique |
| 06/11/2008 | CN101195627A New application of benzo [C] phenanthridine and protopine in producing overriding resistant bacterium medicament |
| 06/11/2008 | CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols |
| 06/11/2008 | CN100393724C 20-esterifiable camptothecine derivative and method for making same and pharmaceutical combination and uses |
| 06/11/2008 | CN100393720C Cyclic benzimidazoles |
| 06/11/2008 | CN100393714C Gyrase inhibitors and uses thereof |
| 06/10/2008 | US7385056 Directly hydrogenating a heteroaryl alpha-hydroxyacetamide in the presence of a strong acid, a halide and a catalyst; for example, the heteroaryl acetamide is zolpidem and the heteroaryl alpha-hydroxyacetamide is alpha-hydroxyzolpidem |
| 06/10/2008 | US7384958 Quinoline inhibitors of cGMP phosphodiesterase |
| 06/10/2008 | US7384957 3,4-dihydro-1H-isoquinolin-2-yl-derivatives |
| 06/10/2008 | US7384955 N-[1-(cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-2,2-dimethyl-propanamide; cannabinoid CB1/CB2 receptor agonists; analgesic; in therapy, in particular in the management of pain |
| 06/10/2008 | US7384949 For therapy and prophylaxis of disorder in which the blocking of purine receptors, particularly adenosine receptors and more may be beneficial, such a Parkinson's disease or depression, cognitive or memory impairment, pain |
| 06/10/2008 | US7384947 Treating cancer with anticarcinogenic agents 3-Amino-9-chloro-5,6,7,8-tetrahydro-naphtho[2,3-b]furan-2-yl))-(2-methyl-pyridin-3-yl)-methanone; antiproliferative agents |
| 06/05/2008 | WO2008065508A1 Spiroketone acetyl-coa carboxylase inhibitors |
| 06/05/2008 | WO2008043791A3 Thiophene derivatives for treating hepatitis c |
| 06/05/2008 | US20080132530 polymorphic forms alpha , beta and gamma; for the oral or topical route; In case of invasive bacteria, it may be useful to use the most bioavailable polymorphic form, whereas in case of non-invasive pathogens it may be more appropriate to use the less adsorbed forms, since they are safer |
| 06/05/2008 | US20080132516 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS |
| 06/05/2008 | US20080132484 Screening for a modulator of Polio Like Kinase, designing and identifying small molecule inhibitors using a homology model for PLK |
| 06/05/2008 | DE102006057036A1 New biphenyl substituted spirocyclic ketoenol derivatives useful for the manufacture of herbicides and for combating parasites |
| 06/04/2008 | EP1926826A2 Class iia histone deacetylase (hdac) substrate |
| 06/04/2008 | EP1926721A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 06/04/2008 | CN101193895A Process for producing tricyclic ketone |
| 06/04/2008 | CN101193862A Hydroxybenzamide derivatives and their use as inhibitors of HSP90 |
| 06/04/2008 | CN101190918A Microwave hydrolysis method for using pyrano[3,2-g]quinolin-2,8-diformic acid ester derivative to prepare dicarboxylic acid of the same |
| 06/04/2008 | CN100391960C Chemical semi-synthetic process for high-purity 10-hydroxy-camptothecin |
| 06/03/2008 | US7381720 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 06/03/2008 | CA2401711C Cyclic amide derivatives |
| 05/29/2008 | WO2008063667A1 Heterotricyclic metalloprotease inhibitors |
| 05/29/2008 | WO2008062013A1 Preparation of 4-substituted 2-amino-benzo[4,5]furo [3,2-d]pyrimidine derivatives |
| 05/29/2008 | WO2008043846A3 New isocarbostyril alkaloid derivatives having anti-proliferative and anti-migratory activities |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | US20080125455 disorders of the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus; sleep apnea; (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine and (S)-1-[1-(1,2,3,6,7,8-hexahydrocyclopent[g]indolyl)]-2-propylamine |
| 05/29/2008 | US20080125452 Indolopyridines,Benzofuranopyridines and Benzothienopyridines |
| 05/29/2008 | US20080125433 Method of treating hair loss using thyromimetic compounds |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | CA2706070A1 Therapeutic tetrahydroisoquinoline-based compositions for cancer therapy |
| 05/29/2008 | CA2670026A1 Heterotricyclic metalloprotease inhibitors |
| 05/29/2008 | CA2669083A1 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents |
| 05/28/2008 | EP1925619A1 Preparation of 4-substituted 2-amino-benzo[4,5]furo[3,2-d]pyrimidine derivatives |
| 05/28/2008 | CN101189243A Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors |
| 05/28/2008 | CN101186613A Cytotoxic agents comprising new maytansinoids |
| 05/28/2008 | CN101186609A Methods of preparing and purifying 9-nitro-20-camptothecin and 9-nitro-20-camptothecin and its compositions |
| 05/28/2008 | CN100390177C Preparation method of 6-cyano-7-methyl-1,1-(2,2-dimethyl-1,3-propylidine dioxy)-5-oxo-1,2,3,5-tetrahydro indolidin (I) |
| 05/28/2008 | CN100390149C Indazole derivatives |
| 05/27/2008 | US7378555 Method of synthesizing camptothecin-relating compounds |
| 05/27/2008 | US7378533 reversible Diels-Alder reaction between functionalized furan and a N-(sulfoaklyl or sulfophenyl)maleimide; exo-4-Dodecyl-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboxy-N-(4-sodium sulfophenyl)imide from N-(4-sodium sulfophenyl)maleimide and 2-dodecylfuran; N-sulfoalkyl 4,7-EPOXYISOINDOLE, 1,3-dione |
| 05/27/2008 | US7378532 Anticancer agents; such as succinic acid mono-[5-(1-benzyl-1H-indazol-3-yl)-furan-2-ylmethyl]ester, sodium salt; inhibit cancer cell growth |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378428 phosphodiesterase inhibitors; (Z)-2-(7-bromomethyl-3,3-dimethyl-3,4-dihydro-(2H)-isoquinolin-1-ylidene)-1-(adamantan-1-yl)ethan-1-one; graft versus host disease, osteoporosis, bone fracture, restenosis, arteriosclerosis, obesity, ischemic reperfusion injury, depression, allergies, transplant rejection |
| 05/27/2008 | US7378426 Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
| 05/27/2008 | US7378194 Materials useful as electrolytic solutes |
| 05/27/2008 | CA2568954A1 Synthesis of spirocyclic glucose-proline hybrids and methods of use |
| 05/27/2008 | CA2514473C Fused bicyclic nitrogen-containing heterocycles |
| 05/22/2008 | WO2008060767A2 Macrocyclic benzofused pyrimidine derivatives |